Erratum: Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases (International Journal of Obesity (2011) 35 (676-683) DOI: 10.1038/ijo.2010.166);Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases

International Journal of Obesity

Volumn 35, Issue 5, 2011, Pages 676-683

  Sarzynski, M A ^a   Jacobson, P ^b   Rankinen, T ^a   Carlsson, B ^b   Sjostrom L ^b   Bouchard, C ^a   Carlsson, L M S ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

genetics; intervention; longitudinal study; polymorphism; Severe obesity

Indexed keywords

ADIPONECTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL NUCLEUS RECEPTOR; DNA; FAT MASS AND OBESITY ASSOCIATED PROTEIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN 4 RECEPTOR; NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BARIATRIC SURGERY; DNA SEQUENCE; FEMALE; FOLLOW UP; GASTRIC BANDING; GASTROPLASTY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BYPASS; VERTICAL BANDED GASTROPLASTY; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 79955848617     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.81     Document Type: Erratum

References (40)

1. WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1-253.
2. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-752. (Pubitemid 47295641)
3. Deitel M. Overview of operations for morbid obesity. World J Surg 1998; 22: 913-918. (Pubitemid 28374608)
4. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693. (Pubitemid 39665322)
5. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753-761. (Pubitemid 47295642)
6. Sjostrom L, Gummesson A, Sjostrom CD, Narbro K, Peltonen M, Wedel H et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653-662.
7. Hsu LK, Benotti PN, Dwyer J, Roberts SB, Saltzman E, Shikora S et al. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med 1998; 60: 338-346. (Pubitemid 28279979)
8. Lancaster K, Burgard M, Howell L, Krahn D, Crosby R, Wonderlich S et al. Long-term follow-up of patients' status after gastric bypass. Obes Surg 2001; 11: 464-468. (Pubitemid 32682160)
9. Bouchard C, Tremblay A, Despres JP, Theriault G, Nadeau A, Lupien PJ et al. The response to exercise with constant energy intake in identical twins. Obes Res 1994; 2: 400-410.
10. Hainer V, Stunkard AJ, Kunesová M, Paŕzková J, Stich V, Allison DB. Intrapair resemblance in very low calorie diet-induced weight loss in female obese identical twins. Int J Obes Relat Metab Disord 2000; 24: 1051-1057. (Pubitemid 30618126)
11. Hofker M, Wijmenga C. A supersized list of obesity genes. Nat Genet 2009; 41: 139-140.
12. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006; 14: 529-644. (Pubitemid 46219737)
13. Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S et al. Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord 1992; 16: 465-479.
14. International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789-796.
15. De Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-1223. (Pubitemid 41568704)
16. Abecasis GR, Cookson WOC. GOLD-Graphical Overview of Linkage Disequilibrium. Bioinformatics 2000; 16: 182-183.
17. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769. (Pubitemid 38420107)
18. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894. (Pubitemid 46764279)
19. Rankinen T, Rice T, Teran-Garcia M, Rao DC, Bouchard C. FTO genotype is associated with exercise training-induced changes in body composition. Obesity (Silver Spring) 2010; 18: 322-326.
20. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775. (Pubitemid 351748863)
21. Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009; 41: 157-159.
22. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, Helgadottir A et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
23. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, Heid IM et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
24. Haupt A, Thamer C, Machann J, Kirchhoff K, Stefan N, Tschritter O et al. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring) 2008; 16: 1969-1972.
25. Lappalainen TJ, Tolppanen AM, Kolehmainen M, Schwab U, Lindstrom J, Tuomilehto J et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight: the Finnish Diabetes Prevention Study. Obesity (Silver Spring) 2009; 17: 832-836.
26. Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC et al. Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 2008; 51: 2214-2223.
27. Muller TD, Hinney A, Scherag A, Nguyen TT, Schreiner F, Schafer H et al. 'Fat mass and obesity associated' gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Med Genet 2008; 9: 85.
28. Haupt A, Thamer C, Heni M, Tschritter O, Machann J, Schick F et al. Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss. Obesity (Silver Spring) 2009; 17: 1942-1945.
29. Nicklas BJ, Van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001; 50: 2172-2176. (Pubitemid 33643689)
30. Lindi VI, Uusitupa MI, Lindstrom J, Louheranta A, Eriksson JG, Valle TT et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002; 51: 2581-2586. (Pubitemid 34827410)
31. Matsuo T, Nakata Y, Katayama Y, Iemitsu M, Maeda S, Okura T et al. PPARG genotype accounts for part of individual variation in body weight reduction in response to calorie restriction. Obesity (Silver Spring) 2009; 17: 1924-1931.
32. Zacharova J, Chiasson JL, Laakso M. Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance. Obes Res 2005; 13: 501-506.
33. Zacharova J, Chiasson JL, Laakso M. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 2005; 54: 893-899. (Pubitemid 40322096)
34. Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004; 135: 326-351. (Pubitemid 38297385)
35. Sesti G, Perego L, Cardellini M, Andreozzi F, Ricasoli C, Vedani P et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 2005; 90: 5064-5069. (Pubitemid 41262255)
36. Potoczna N, Branson R, Kral JG, Piec G, Steffen R, Ricklin T et al. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg 2004; 8: 971-981.
37. Potoczna N, Wertli M, Steffen R, Ricklin T, Lentes KU, Horber FF. G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients. J Gastrointest Surg 2004; 8: 862-868. (Pubitemid 41115740)
38. Chen HH, Lee WJ, Wang W, Huang MT, Lee YC, Pan WH. Ala55Val polymorphism on UCP2 gene predicts greater weight loss in morbidly obese patients undergoing gastric banding. Obes Surg 2007; 17: 926-933. (Pubitemid 350042921)
39. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002; 87: 3555-3561. (Pubitemid 34879496)
40. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613-624. (Pubitemid 17103382)